Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kathryn Fitzgerald

Nurse Practitioner, Pediatrics New York, NY Nurse Practitioner

NPI 1205936747 CMS profile 11230116

160 E 32Nd St Fl 2, New York, NY 10016

Open in the dashboard

General payments

$79,545

363 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kathryn Fitzgerald of New York, NY is reported in the CMS Open Payments database as having received $79,545 across 363 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,603 68
2024 General $32,184 171
2023 General $221 7
2022 General $16,173 80
2021 General $17,363 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kathryn Fitzgerald
  • Nurse Practitioner, Pediatrics median
  • Middle half of Nurse Practitioner, Pediatrics
  • National median

In program year 2025, general payments to Kathryn Fitzgerald were reported at $13,603. Among 7,458 Nurse Practitioner, Pediatrics profiles paid that year, the median was $93 and the middle half received between $35 and $201.

Show as a table
Year Kathryn Fitzgerald Nurse Practitioner, Pediatrics median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $17,363 $60 $23–$142 $132
2022 $16,173 $72 $27–$161 $149
2023 $221 $89 $35–$185 $160
2024 $32,184 $93 $34–$199 $164
2025 $13,603 $93 $35–$201 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Baxter Healthcare $61,728 310 payments
  2. Advanced Respiratory, Inc $17,228 35 payments
  3. Genzyme Corporation $208 6 payments
  4. AstraZeneca Pharmaceuticals LP $153 3 payments
  5. Regeneron Healthcare Solutions, Inc. $106 4 payments
  6. Amgen Inc. $58 2 payments
  7. GlaxoSmithKline, LLC. $48 2 payments
  8. Nestle HealthCare Nutrition Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $61,403 220 payments
  2. Education $15,600 63 payments
  3. Travel and Lodging $1,643 44 payments
  4. Food and Beverage $899 36 payments
Products named General payments · program years 2021–2025
  1. Hillrom - Synclara Cough System $40,735 203 payments
  2. Hillrom - Vest System Model 205 Acute Care $18,651 79 payments
  3. The Vest System 205 Acute Care $12,231 23 payments
  4. SynclaraCough System Airway Clearance Device $9,104 15 payments
  5. The Monarch Airway Clearance System $4,114 6 payments
  6. SynclaraCough System Airway Clearance Device $2,646 5 payments
  7. Volara System $1,986 4 payments
  8. Hillrom - Volara System $1,089 5 payments
  9. Hillrom - Monarch Airway Clearance System $719 4 payments
  10. Life 2000 Ventilation System $475 2 payments
  11. Other $899 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

363 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record